About The Medical Condition Drug Evaluation, FDA Phase 3
Find the definition of the medical term Drug Evaluation, FDA Phase 3. Drug Evaluation, FDA Phase 3 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 3
| Drug Evaluation, FDA Phase 3 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 3?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Vaccine, Bacterial ‐ Suspensions of attenuated or killed bacteria administered for…
- Biotyping, Mycological ‐ Procedures for identifying types and strains…
- Irrigation ‐ The washing of a body cavity or surface by flowing solution which…
- Horses ‐ Large, hoofed mammals of the family EQUIDAE. Horses are active…
- Poikiloderma Congenitale ‐ An autosomal recessive syndrome occurring principally in females,…
- Trichostomatina ‐ A suborder of ciliate protozoa characterized by non-reduction…
- Carotid Artery Injuries ‐ Blunt and penetrating traumatic injuries of the common, internal,…
- Antepartum CTG ‐ Monitoring of fetal heart frequency before birth in order to…
- Tachycardia, Reciprocal ‐ Condition marked by attacks of rapid action of the heart having…
- Neoplasms, Urethra ‐ Cancer or tumors of the URETHRA. This condition is relatively…